← Eichor
Condition: Clonal Hematopoiesis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Clonal Hematopoiesis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07500441Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors
NA · 1 location(s) · European Institute of Oncology · NCT06785077Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Phase N/A · 1 location(s) · University of Washington · NCT06295965Clonal Hematopoiesis of Indeterminate Potential in Heart Failure.
Phase N/A · 2 location(s) · FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · NCT06626685A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Phase N/A · 32 location(s) · Children's Oncology Group · NCT05705531Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
NA · 3 location(s) · Mayo Clinic · NCT02958462Nucleoside Therapy in Patients With Telomere Biology Disorders
Phase 1 · 1 location(s) · Suneet Agarwal · NCT06817590Donor CHIP and Allogeneic HSCT Outcome
Phase N/A · 1 location(s) · The University of Hong Kong · NCT04689750Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT07675967Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT06691217Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
Phase 1 · 1 location(s) · Brigham and Women's Hospital · NCT07249840A Dietary Study for People With Clonal Hematopoiesis
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07590804Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06303193Aging, Geriatric Syndromes and Clonal Hematopoiesis
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT02604563Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications
Phase N/A · 1 location(s) · Sunnybrook Health Sciences Centre · NCT04053439Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
NA · 7 location(s) · University Hospital, Bordeaux · NCT05711173Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
Phase N/A · 1 location(s) · Imelda Hospital, Bonheiden · NCT05246813Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis
Phase 4 · 1 location(s) · Shenyang Northern Hospital · NCT07362966The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository
Phase N/A · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06701214Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
Phase N/A · 3 location(s) · Dana-Farber Cancer Institute · NCT04541654CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research
Phase N/A · 1 location(s) · Clinical Hub for Interventional Research (CHOIR) · NCT07313059Pre-malignant States to Hematologic Malignancies in Firefighters
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT06870760CHIP/CCUS Natural History Protocol
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT04102423Is Clonal Hematopoiesis of Indeterminate Potential Associated With Unprovoked Pulmonary Embolism?
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT04711746
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.